Global Mumps Drug Market Growth 2025-2031

January 2025 | 99 pages | ID: G006C625B3C1EN
LP Information

US$ 3,660.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The report requires updating with new data and is sent in 48 hours after order is placed.

The global Mumps Drug market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

LP Information, Inc. (LPI) ' newest research report, the “Mumps Drug Industry Forecast” looks at past sales and reviews total world Mumps Drug sales in 2024, providing a comprehensive analysis by region and market sector of projected Mumps Drug sales for 2025 through 2031. With Mumps Drug sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Mumps Drug industry.

This Insight Report provides a comprehensive analysis of the global Mumps Drug landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Mumps Drug portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Mumps Drug market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Mumps Drug and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Mumps Drug.

This report presents a comprehensive overview, market shares, and growth opportunities of Mumps Drug market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
  • RIT 4385
  • Schwarz
  • Wistar RA 27/3
  • Others
Segmentation by Application:
  • Hospital
  • Clinic
  • Others
This report also splits the market by region:
  • Americas
    • United States
    • Canada
    • Mexico
    • Brazil
  • APAC
    • China
    • Japan
    • Korea
    • Southeast Asia
    • India
    • Australia
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
  • Middle East & Africa
    • Egypt
    • South Africa
    • Israel
    • Turkey
    • GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
  • Beijing Minhai Biotechnology Co., Ltd
  • Beijing Tiantan Biological Products Co., Ltd.
  • China National Pharmaceutical Group Corporation
  • GlaxoSmithKline Plc
  • Organic Vaccines
  • Prometheon Pharma, LLC
  • Sinovac Biotech Ltd.
  • Zydus Cadila Healthcare Limited
Key Questions Addressed in this Report

What is the 10-year outlook for the global Mumps Drug market?

What factors are driving Mumps Drug market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Mumps Drug market opportunities vary by end market size?

How does Mumps Drug break out by Type, by Application?
1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Mumps Drug Annual Sales 2020-2031
  2.1.2 World Current & Future Analysis for Mumps Drug by Geographic Region, 2020, 2024 & 2031
  2.1.3 World Current & Future Analysis for Mumps Drug by Country/Region, 2020, 2024 & 2031
2.2 Mumps Drug Segment by Type
  2.2.1 RIT 4385
  2.2.2 Schwarz
  2.2.3 Wistar RA 27/3
  2.2.4 Others
2.3 Mumps Drug Sales by Type
  2.3.1 Global Mumps Drug Sales Market Share by Type (2020-2025)
  2.3.2 Global Mumps Drug Revenue and Market Share by Type (2020-2025)
  2.3.3 Global Mumps Drug Sale Price by Type (2020-2025)
2.4 Mumps Drug Segment by Application
  2.4.1 Hospital
  2.4.2 Clinic
  2.4.3 Others
2.5 Mumps Drug Sales by Application
  2.5.1 Global Mumps Drug Sale Market Share by Application (2020-2025)
  2.5.2 Global Mumps Drug Revenue and Market Share by Application (2020-2025)
  2.5.3 Global Mumps Drug Sale Price by Application (2020-2025)

3 GLOBAL BY COMPANY

3.1 Global Mumps Drug Breakdown Data by Company
  3.1.1 Global Mumps Drug Annual Sales by Company (2020-2025)
  3.1.2 Global Mumps Drug Sales Market Share by Company (2020-2025)
3.2 Global Mumps Drug Annual Revenue by Company (2020-2025)
  3.2.1 Global Mumps Drug Revenue by Company (2020-2025)
  3.2.2 Global Mumps Drug Revenue Market Share by Company (2020-2025)
3.3 Global Mumps Drug Sale Price by Company
3.4 Key Manufacturers Mumps Drug Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Mumps Drug Product Location Distribution
  3.4.2 Players Mumps Drug Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy

4 WORLD HISTORIC REVIEW FOR MUMPS DRUG BY GEOGRAPHIC REGION

4.1 World Historic Mumps Drug Market Size by Geographic Region (2020-2025)
  4.1.1 Global Mumps Drug Annual Sales by Geographic Region (2020-2025)
  4.1.2 Global Mumps Drug Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Mumps Drug Market Size by Country/Region (2020-2025)
  4.2.1 Global Mumps Drug Annual Sales by Country/Region (2020-2025)
  4.2.2 Global Mumps Drug Annual Revenue by Country/Region (2020-2025)
4.3 Americas Mumps Drug Sales Growth
4.4 APAC Mumps Drug Sales Growth
4.5 Europe Mumps Drug Sales Growth
4.6 Middle East & Africa Mumps Drug Sales Growth

5 AMERICAS

5.1 Americas Mumps Drug Sales by Country
  5.1.1 Americas Mumps Drug Sales by Country (2020-2025)
  5.1.2 Americas Mumps Drug Revenue by Country (2020-2025)
5.2 Americas Mumps Drug Sales by Type (2020-2025)
5.3 Americas Mumps Drug Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Mumps Drug Sales by Region
  6.1.1 APAC Mumps Drug Sales by Region (2020-2025)
  6.1.2 APAC Mumps Drug Revenue by Region (2020-2025)
6.2 APAC Mumps Drug Sales by Type (2020-2025)
6.3 APAC Mumps Drug Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Mumps Drug by Country
  7.1.1 Europe Mumps Drug Sales by Country (2020-2025)
  7.1.2 Europe Mumps Drug Revenue by Country (2020-2025)
7.2 Europe Mumps Drug Sales by Type (2020-2025)
7.3 Europe Mumps Drug Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Mumps Drug by Country
  8.1.1 Middle East & Africa Mumps Drug Sales by Country (2020-2025)
  8.1.2 Middle East & Africa Mumps Drug Revenue by Country (2020-2025)
8.2 Middle East & Africa Mumps Drug Sales by Type (2020-2025)
8.3 Middle East & Africa Mumps Drug Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Mumps Drug
10.3 Manufacturing Process Analysis of Mumps Drug
10.4 Industry Chain Structure of Mumps Drug

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Mumps Drug Distributors
11.3 Mumps Drug Customer

12 WORLD FORECAST REVIEW FOR MUMPS DRUG BY GEOGRAPHIC REGION

12.1 Global Mumps Drug Market Size Forecast by Region
  12.1.1 Global Mumps Drug Forecast by Region (2026-2031)
  12.1.2 Global Mumps Drug Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Mumps Drug Forecast by Type (2026-2031)
12.7 Global Mumps Drug Forecast by Application (2026-2031)

13 KEY PLAYERS ANALYSIS

13.1 Beijing Minhai Biotechnology Co., Ltd
  13.1.1 Beijing Minhai Biotechnology Co., Ltd Company Information
  13.1.2 Beijing Minhai Biotechnology Co., Ltd Mumps Drug Product Portfolios and Specifications
  13.1.3 Beijing Minhai Biotechnology Co., Ltd Mumps Drug Sales, Revenue, Price and Gross Margin (2020-2025)
  13.1.4 Beijing Minhai Biotechnology Co., Ltd Main Business Overview
  13.1.5 Beijing Minhai Biotechnology Co., Ltd Latest Developments
13.2 Beijing Tiantan Biological Products Co., Ltd.
  13.2.1 Beijing Tiantan Biological Products Co., Ltd. Company Information
  13.2.2 Beijing Tiantan Biological Products Co., Ltd. Mumps Drug Product Portfolios and Specifications
  13.2.3 Beijing Tiantan Biological Products Co., Ltd. Mumps Drug Sales, Revenue, Price and Gross Margin (2020-2025)
  13.2.4 Beijing Tiantan Biological Products Co., Ltd. Main Business Overview
  13.2.5 Beijing Tiantan Biological Products Co., Ltd. Latest Developments
13.3 China National Pharmaceutical Group Corporation
  13.3.1 China National Pharmaceutical Group Corporation Company Information
  13.3.2 China National Pharmaceutical Group Corporation Mumps Drug Product Portfolios and Specifications
  13.3.3 China National Pharmaceutical Group Corporation Mumps Drug Sales, Revenue, Price and Gross Margin (2020-2025)
  13.3.4 China National Pharmaceutical Group Corporation Main Business Overview
  13.3.5 China National Pharmaceutical Group Corporation Latest Developments
13.4 GlaxoSmithKline Plc
  13.4.1 GlaxoSmithKline Plc Company Information
  13.4.2 GlaxoSmithKline Plc Mumps Drug Product Portfolios and Specifications
  13.4.3 GlaxoSmithKline Plc Mumps Drug Sales, Revenue, Price and Gross Margin (2020-2025)
  13.4.4 GlaxoSmithKline Plc Main Business Overview
  13.4.5 GlaxoSmithKline Plc Latest Developments
13.5 Organic Vaccines
  13.5.1 Organic Vaccines Company Information
  13.5.2 Organic Vaccines Mumps Drug Product Portfolios and Specifications
  13.5.3 Organic Vaccines Mumps Drug Sales, Revenue, Price and Gross Margin (2020-2025)
  13.5.4 Organic Vaccines Main Business Overview
  13.5.5 Organic Vaccines Latest Developments
13.6 Prometheon Pharma, LLC
  13.6.1 Prometheon Pharma, LLC Company Information
  13.6.2 Prometheon Pharma, LLC Mumps Drug Product Portfolios and Specifications
  13.6.3 Prometheon Pharma, LLC Mumps Drug Sales, Revenue, Price and Gross Margin (2020-2025)
  13.6.4 Prometheon Pharma, LLC Main Business Overview
  13.6.5 Prometheon Pharma, LLC Latest Developments
13.7 Sinovac Biotech Ltd.
  13.7.1 Sinovac Biotech Ltd. Company Information
  13.7.2 Sinovac Biotech Ltd. Mumps Drug Product Portfolios and Specifications
  13.7.3 Sinovac Biotech Ltd. Mumps Drug Sales, Revenue, Price and Gross Margin (2020-2025)
  13.7.4 Sinovac Biotech Ltd. Main Business Overview
  13.7.5 Sinovac Biotech Ltd. Latest Developments
13.8 Zydus Cadila Healthcare Limited
  13.8.1 Zydus Cadila Healthcare Limited Company Information
  13.8.2 Zydus Cadila Healthcare Limited Mumps Drug Product Portfolios and Specifications
  13.8.3 Zydus Cadila Healthcare Limited Mumps Drug Sales, Revenue, Price and Gross Margin (2020-2025)
  13.8.4 Zydus Cadila Healthcare Limited Main Business Overview
  13.8.5 Zydus Cadila Healthcare Limited Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION


LIST OFTABLES

Table 1. Mumps Drug Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Mumps Drug Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of RIT 4385
Table 4. Major Players of Schwarz
Table 5. Major Players of Wistar RA 27/3
Table 6. Major Players of Others
Table 7. Global Mumps Drug Sales byType (2020-2025) & (K Pcs)
Table 8. Global Mumps Drug Sales Market Share byType (2020-2025)
Table 9. Global Mumps Drug Revenue byType (2020-2025) & ($ million)
Table 10. Global Mumps Drug Revenue Market Share byType (2020-2025)
Table 11. Global Mumps Drug Sale Price byType (2020-2025) & (USD/Pcs)
Table 12. Global Mumps Drug Sale by Application (2020-2025) & (K Pcs)
Table 13. Global Mumps Drug Sale Market Share by Application (2020-2025)
Table 14. Global Mumps Drug Revenue by Application (2020-2025) & ($ million)
Table 15. Global Mumps Drug Revenue Market Share by Application (2020-2025)
Table 16. Global Mumps Drug Sale Price by Application (2020-2025) & (USD/Pcs)
Table 17. Global Mumps Drug Sales by Company (2020-2025) & (K Pcs)
Table 18. Global Mumps Drug Sales Market Share by Company (2020-2025)
Table 19. Global Mumps Drug Revenue by Company (2020-2025) & ($ millions)
Table 20. Global Mumps Drug Revenue Market Share by Company (2020-2025)
Table 21. Global Mumps Drug Sale Price by Company (2020-2025) & (USD/Pcs)
Table 22. Key Manufacturers Mumps Drug Producing Area Distribution and Sales Area
Table 23. Players Mumps Drug Products Offered
Table 24. Mumps Drug Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 25. New Products and Potential Entrants
Table 26. Market M&A Activity & Strategy
Table 27. Global Mumps Drug Sales by Geographic Region (2020-2025) & (K Pcs)
Table 28. Global Mumps Drug Sales Market Share Geographic Region (2020-2025)
Table 29. Global Mumps Drug Revenue by Geographic Region (2020-2025) & ($ millions)
Table 30. Global Mumps Drug Revenue Market Share by Geographic Region (2020-2025)
Table 31. Global Mumps Drug Sales by Country/Region (2020-2025) & (K Pcs)
Table 32. Global Mumps Drug Sales Market Share by Country/Region (2020-2025)
Table 33. Global Mumps Drug Revenue by Country/Region (2020-2025) & ($ millions)
Table 34. Global Mumps Drug Revenue Market Share by Country/Region (2020-2025)
Table 35. Americas Mumps Drug Sales by Country (2020-2025) & (K Pcs)
Table 36. Americas Mumps Drug Sales Market Share by Country (2020-2025)
Table 37. Americas Mumps Drug Revenue by Country (2020-2025) & ($ millions)
Table 38. Americas Mumps Drug Sales byType (2020-2025) & (K Pcs)
Table 39. Americas Mumps Drug Sales by Application (2020-2025) & (K Pcs)
Table 40. APAC Mumps Drug Sales by Region (2020-2025) & (K Pcs)
Table 41. APAC Mumps Drug Sales Market Share by Region (2020-2025)
Table 42. APAC Mumps Drug Revenue by Region (2020-2025) & ($ millions)
Table 43. APAC Mumps Drug Sales byType (2020-2025) & (K Pcs)
Table 44. APAC Mumps Drug Sales by Application (2020-2025) & (K Pcs)
Table 45. Europe Mumps Drug Sales by Country (2020-2025) & (K Pcs)
Table 46. Europe Mumps Drug Revenue by Country (2020-2025) & ($ millions)
Table 47. Europe Mumps Drug Sales byType (2020-2025) & (K Pcs)
Table 48. Europe Mumps Drug Sales by Application (2020-2025) & (K Pcs)
Table 49. Middle East & Africa Mumps Drug Sales by Country (2020-2025) & (K Pcs)
Table 50. Middle East & Africa Mumps Drug Revenue Market Share by Country (2020-2025)
Table 51. Middle East & Africa Mumps Drug Sales byType (2020-2025) & (K Pcs)
Table 52. Middle East & Africa Mumps Drug Sales by Application (2020-2025) & (K Pcs)
Table 53. Key Market Drivers & Growth Opportunities of Mumps Drug
Table 54. Key Market Challenges & Risks of Mumps Drug
Table 55. Key IndustryTrends of Mumps Drug
Table 56. Mumps Drug Raw Material
Table 57. Key Suppliers of Raw Materials
Table 58. Mumps Drug Distributors List
Table 59. Mumps Drug Customer List
Table 60. Global Mumps Drug SalesForecast by Region (2026-2031) & (K Pcs)
Table 61. Global Mumps Drug RevenueForecast by Region (2026-2031) & ($ millions)
Table 62. Americas Mumps Drug SalesForecast by Country (2026-2031) & (K Pcs)
Table 63. Americas Mumps Drug Annual RevenueForecast by Country (2026-2031) & ($ millions)
Table 64. APAC Mumps Drug SalesForecast by Region (2026-2031) & (K Pcs)
Table 65. APAC Mumps Drug Annual RevenueForecast by Region (2026-2031) & ($ millions)
Table 66. Europe Mumps Drug SalesForecast by Country (2026-2031) & (K Pcs)
Table 67. Europe Mumps Drug RevenueForecast by Country (2026-2031) & ($ millions)
Table 68. Middle East & Africa Mumps Drug SalesForecast by Country (2026-2031) & (K Pcs)
Table 69. Middle East & Africa Mumps Drug RevenueForecast by Country (2026-2031) & ($ millions)
Table 70. Global Mumps Drug SalesForecast byType (2026-2031) & (K Pcs)
Table 71. Global Mumps Drug RevenueForecast byType (2026-2031) & ($ millions)
Table 72. Global Mumps Drug SalesForecast by Application (2026-2031) & (K Pcs)
Table 73. Global Mumps Drug RevenueForecast by Application (2026-2031) & ($ millions)
Table 74. Beijing Minhai Biotechnology Co., Ltd Basic Information, Mumps Drug Manufacturing Base, Sales Area and Its Competitors
Table 75. Beijing Minhai Biotechnology Co., Ltd Mumps Drug Product Portfolios and Specifications
Table 76. Beijing Minhai Biotechnology Co., Ltd Mumps Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 77. Beijing Minhai Biotechnology Co., Ltd Main Business
Table 78. Beijing Minhai Biotechnology Co., Ltd Latest Developments
Table 79. BeijingTiantan Biological Products Co., Ltd. Basic Information, Mumps Drug Manufacturing Base, Sales Area and Its Competitors
Table 80. BeijingTiantan Biological Products Co., Ltd. Mumps Drug Product Portfolios and Specifications
Table 81. BeijingTiantan Biological Products Co., Ltd. Mumps Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 82. BeijingTiantan Biological Products Co., Ltd. Main Business
Table 83. BeijingTiantan Biological Products Co., Ltd. Latest Developments
Table 84. China National Pharmaceutical Group Corporation Basic Information, Mumps Drug Manufacturing Base, Sales Area and Its Competitors
Table 85. China National Pharmaceutical Group Corporation Mumps Drug Product Portfolios and Specifications
Table 86. China National Pharmaceutical Group Corporation Mumps Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 87. China National Pharmaceutical Group Corporation Main Business
Table 88. China National Pharmaceutical Group Corporation Latest Developments
Table 89. GlaxoSmithKline Plc Basic Information, Mumps Drug Manufacturing Base, Sales Area and Its Competitors
Table 90. GlaxoSmithKline Plc Mumps Drug Product Portfolios and Specifications
Table 91. GlaxoSmithKline Plc Mumps Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 92. GlaxoSmithKline Plc Main Business
Table 93. GlaxoSmithKline Plc Latest Developments
Table 94. Organic Vaccines Basic Information, Mumps Drug Manufacturing Base, Sales Area and Its Competitors
Table 95. Organic Vaccines Mumps Drug Product Portfolios and Specifications
Table 96. Organic Vaccines Mumps Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 97. Organic Vaccines Main Business
Table 98. Organic Vaccines Latest Developments
Table 99. Prometheon Pharma, LLC Basic Information, Mumps Drug Manufacturing Base, Sales Area and Its Competitors
Table 100. Prometheon Pharma, LLC Mumps Drug Product Portfolios and Specifications
Table 101. Prometheon Pharma, LLC Mumps Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 102. Prometheon Pharma, LLC Main Business
Table 103. Prometheon Pharma, LLC Latest Developments
Table 104. Sinovac Biotech Ltd. Basic Information, Mumps Drug Manufacturing Base, Sales Area and Its Competitors
Table 105. Sinovac Biotech Ltd. Mumps Drug Product Portfolios and Specifications
Table 106. Sinovac Biotech Ltd. Mumps Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 107. Sinovac Biotech Ltd. Main Business
Table 108. Sinovac Biotech Ltd. Latest Developments
Table 109. Zydus Cadila Healthcare Limited Basic Information, Mumps Drug Manufacturing Base, Sales Area and Its Competitors
Table 110. Zydus Cadila Healthcare Limited Mumps Drug Product Portfolios and Specifications
Table 111. Zydus Cadila Healthcare Limited Mumps Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 112. Zydus Cadila Healthcare Limited Main Business
Table 113. Zydus Cadila Healthcare Limited Latest Developments



LIST OFFIGURES

Figure 1. Picture of Mumps Drug
Figure 2. Mumps Drug Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Mumps Drug Sales Growth Rate 2020-2031 (K Pcs)
Figure 7. Global Mumps Drug Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Mumps Drug Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Mumps Drug Sales Market Share by Country/Region (2024)
Figure 10. Mumps Drug Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of RIT 4385
Figure 12. Product Picture of Schwarz
Figure 13. Product Picture of Wistar RA 27/3
Figure 14. Product Picture of Others
Figure 15. Global Mumps Drug Sales Market Share byType in 2025
Figure 16. Global Mumps Drug Revenue Market Share byType (2020-2025)
Figure 17. Mumps Drug Consumed in Hospital
Figure 18. Global Mumps Drug Market: Hospital (2020-2025) & (K Pcs)
Figure 19. Mumps Drug Consumed in Clinic
Figure 20. Global Mumps Drug Market: Clinic (2020-2025) & (K Pcs)
Figure 21. Mumps Drug Consumed in Others
Figure 22. Global Mumps Drug Market: Others (2020-2025) & (K Pcs)
Figure 23. Global Mumps Drug Sale Market Share by Application (2024)
Figure 24. Global Mumps Drug Revenue Market Share by Application in 2025
Figure 25. Mumps Drug Sales by Company in 2025 (K Pcs)
Figure 26. Global Mumps Drug Sales Market Share by Company in 2025
Figure 27. Mumps Drug Revenue by Company in 2025 ($ millions)
Figure 28. Global Mumps Drug Revenue Market Share by Company in 2025
Figure 29. Global Mumps Drug Sales Market Share by Geographic Region (2020-2025)
Figure 30. Global Mumps Drug Revenue Market Share by Geographic Region in 2025
Figure 31. Americas Mumps Drug Sales 2020-2025 (K Pcs)
Figure 32. Americas Mumps Drug Revenue 2020-2025 ($ millions)
Figure 33. APAC Mumps Drug Sales 2020-2025 (K Pcs)
Figure 34. APAC Mumps Drug Revenue 2020-2025 ($ millions)
Figure 35. Europe Mumps Drug Sales 2020-2025 (K Pcs)
Figure 36. Europe Mumps Drug Revenue 2020-2025 ($ millions)
Figure 37. Middle East & Africa Mumps Drug Sales 2020-2025 (K Pcs)
Figure 38. Middle East & Africa Mumps Drug Revenue 2020-2025 ($ millions)
Figure 39. Americas Mumps Drug Sales Market Share by Country in 2025
Figure 40. Americas Mumps Drug Revenue Market Share by Country (2020-2025)
Figure 41. Americas Mumps Drug Sales Market Share byType (2020-2025)
Figure 42. Americas Mumps Drug Sales Market Share by Application (2020-2025)
Figure 43. United States Mumps Drug Revenue Growth 2020-2025 ($ millions)
Figure 44. Canada Mumps Drug Revenue Growth 2020-2025 ($ millions)
Figure 45. Mexico Mumps Drug Revenue Growth 2020-2025 ($ millions)
Figure 46. Brazil Mumps Drug Revenue Growth 2020-2025 ($ millions)
Figure 47. APAC Mumps Drug Sales Market Share by Region in 2025
Figure 48. APAC Mumps Drug Revenue Market Share by Region (2020-2025)
Figure 49. APAC Mumps Drug Sales Market Share byType (2020-2025)
Figure 50. APAC Mumps Drug Sales Market Share by Application (2020-2025)
Figure 51. China Mumps Drug Revenue Growth 2020-2025 ($ millions)
Figure 52. Japan Mumps Drug Revenue Growth 2020-2025 ($ millions)
Figure 53. South Korea Mumps Drug Revenue Growth 2020-2025 ($ millions)
Figure 54. Southeast Asia Mumps Drug Revenue Growth 2020-2025 ($ millions)
Figure 55. India Mumps Drug Revenue Growth 2020-2025 ($ millions)
Figure 56. Australia Mumps Drug Revenue Growth 2020-2025 ($ millions)
Figure 57. ChinaTaiwan Mumps Drug Revenue Growth 2020-2025 ($ millions)
Figure 58. Europe Mumps Drug Sales Market Share by Country in 2025
Figure 59. Europe Mumps Drug Revenue Market Share by Country (2020-2025)
Figure 60. Europe Mumps Drug Sales Market Share byType (2020-2025)
Figure 61. Europe Mumps Drug Sales Market Share by Application (2020-2025)
Figure 62. Germany Mumps Drug Revenue Growth 2020-2025 ($ millions)
Figure 63.France Mumps Drug Revenue Growth 2020-2025 ($ millions)
Figure 64. UK Mumps Drug Revenue Growth 2020-2025 ($ millions)
Figure 65. Italy Mumps Drug Revenue Growth 2020-2025 ($ millions)
Figure 66. Russia Mumps Drug Revenue Growth 2020-2025 ($ millions)
Figure 67. Middle East & Africa Mumps Drug Sales Market Share by Country (2020-2025)
Figure 68. Middle East & Africa Mumps Drug Sales Market Share byType (2020-2025)
Figure 69. Middle East & Africa Mumps Drug Sales Market Share by Application (2020-2025)
Figure 70. Egypt Mumps Drug Revenue Growth 2020-2025 ($ millions)
Figure 71. South Africa Mumps Drug Revenue Growth 2020-2025 ($ millions)
Figure 72. Israel Mumps Drug Revenue Growth 2020-2025 ($ millions)
Figure 73.Turkey Mumps Drug Revenue Growth 2020-2025 ($ millions)
Figure 74. GCC Countries Mumps Drug Revenue Growth 2020-2025 ($ millions)
Figure 75. Manufacturing Cost Structure Analysis of Mumps Drug in 2025
Figure 76. Manufacturing Process Analysis of Mumps Drug
Figure 77. Industry Chain Structure of Mumps Drug
Figure 78. Channels of Distribution
Figure 79. Global Mumps Drug Sales MarketForecast by Region (2026-2031)
Figure 80. Global Mumps Drug Revenue Market ShareForecast by Region (2026-2031)
Figure 81. Global Mumps Drug Sales Market ShareForecast byType (2026-2031)
Figure 82. Global Mumps Drug Revenue Market ShareForecast byType (2026-2031)
Figure 83. Global Mumps Drug Sales Market ShareForecast by Application (2026-2031)
Figure 84. Global Mumps Drug Revenue Market ShareForecast by Application (2026-2031)